Asthma natural history, complications and prognosis

Revision as of 18:46, 22 September 2011 by Varun Kumar (talk | contribs)
Jump to navigation Jump to search

Asthma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asthma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Pulmonary Function Test
Bronchial Challenge Test
Exhaled nitric oxide

Treatment

Emergency Management

Medical Therapy

Alternative and Complementary Medicine

Bronchial Thermoplasty

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asthma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asthma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asthma natural history, complications and prognosis

CDC on Asthma natural history, complications and prognosis

Asthma natural history, complications and prognosis in the news

Blogs on Asthma natural history, complications and prognosis

Directions to Hospitals Treating Asthma

Risk calculators and risk factors for Asthma natural history, complications and prognosis

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Philip Marcus, M.D., M.P.H. [2]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [3]

Overview

Natural History

Asthma in Children

  • Many children often develop one or more episodes of wheezing early in life. These episodes are often associated with respiratory viral infection[1]. Tucson Children's Respiratory Study which is a longitudinal birth cohort study also demonstrated that the prevalence of wheezing in presence of lower respiratory tract illness was 32%, 17% and 12% at first, second and third year of life, respectively[2]. Respiratory syncytial virus (RSV) followed by parainfluenza virus type 3 are the common causative agents identified[3][4][2]. At age of 6 years, 20% of children who had previous episodes of lower respiratory illness with wheezing during the first three years of life, had no wheezing, 13.7% of children who had wheezing before three years of age continued to have wheezing. 15% of children were reported to have new onset wheezing at 6 years of age. Majority of children with wheeze were associated with transient conditions such as viral illness which do not increase the risk of asthma later in life[5]. Lung function values among children with persistent wheezing were not different from those who never wheezed. However, their IgE levels were elevated[2] suggesting allergic/asthma predisposition. The late-onset wheezing and the persistent wheezing groups had more episodes of wheezing in late childhood and adolescence[6].
  • The Melbourne Asthma Study which is a longitudinal community based study (1964-1999), is considered to reflect the natural course of asthma from childhood (7 years of age) into adult life (42 years of age) as the patients were not optimally treated according to present guidelines. The study demonstrated that the children with few episodes of wheezing associated with respiratory infection had a benign course, with many becoming asymptomatic by adult life. While, those with severe asthma during childhood continued to be symptomatic during adulthood and there was a progressive loss in pulmonary function noted as the patients approached 14 years of age but did not progress in adult life. Loss of lung function was not noted in patients with milder symptoms[7].
  • In another birth cohort study in Dunedin, New Zealand 613 children were followed every 2 years between 3 and 15 years of age and then at 18, 21, and 26 years of age[8]. By 26 years of age, approximately 50% of the cohort had reported wheezing at least once. Bronchodilator response (or a positive methacholine test) and a positive skin test result to mite or cat at 9 years of age, predicted the persistence of asthma at 26 years of age[9].
  • Similar to above mentioned studies, the Childhood Asthma Management Program (CAMP) also reported decline in pulmonary function with age if the onset of asthma is early in childhood. Significant correlation between duration of asthma and decline in lung function, greater methacholine responsiveness, more asthma symptoms, and greater use of as-needed albuterol was noted from the baseline data of 1041 children. In addition it also reported that independent of baseline lung function, the airway responsiveness increased after puberty in girls, but decreased after puberty in boys[10].

Asthma in Adults

Asthma in adults may be of new onset or persistent from childhood. Unlike asthma in children, among adults, asthma is seldom clinically progressive or undergo complete remission. However, rapid rate of decline in lung function may be observed among patients with severe asthma[11][12] or those with new onset asthma as reported in a longitudinal study, The Copenhagen City Heart Study where the decline in lung function was, on average, 39 ml/yr in men and 11 ml/yr in women, respectively, compared with that in nonasthmatic subjects. Among patients with chronic asthma, the rate of lung function decline did not increase compared with that in nonasthmatic subjects[13]. Relapse rates among patients with past history of asthma tend to increase with age[14].

Prognosis

The prognosis for asthmatics is good; especially for children with mild disease. For asthmatics diagnosed during childhood, 54% will no longer carry the diagnosis after a decade. The extent of permanent lung damage in asthmatics is unclear. Airway remodelling is observed, but it is unknown whether these represent harmful or beneficial changes.[15] Although conclusions from studies are mixed, most studies show that early treatment with glucocorticoids prevents or ameliorates decline in lung function as measured by several parameters.[16] For those who continue to suffer from mild symptoms, corticosteroids can help most to live their lives with few disabilities. The mortality rate for asthma is low, with around 6000 deaths per year in a population of some 10 million patients in the United States. Better control of the condition may help prevent some of these deaths.

In a birth cohort study in Dunedin, New Zealand, bronchodilator response (or a positive methacholine test) and a positive skin test result to mite or cat at 9 years of age, predicted the persistence of asthma at 26 years of age[9].

References

  1. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL; et al. (2007). "Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma". J Allergy Clin Immunol. 119 (5): 1105–10. doi:10.1016/j.jaci.2006.12.669. PMID 17353039.
  2. 2.0 2.1 2.2 Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD (2003). "Tucson Children's Respiratory Study: 1980 to present". J Allergy Clin Immunol. 111 (4): 661–75, quiz 676. PMID 12704342.
  3. Henderson FW, Clyde WA, Collier AM, Denny FW, Senior RJ, Sheaffer CI; et al. (1979). "The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice". J Pediatr. 95 (2): 183–90. PMID 448557.
  4. Denny FW, Clyde WA (1986). "Acute lower respiratory tract infections in nonhospitalized children". J Pediatr. 108 (5 Pt 1): 635–46. PMID 3009769.
  5. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ (1995). "Asthma and wheezing in the first six years of life. The Group Health Medical Associates". N Engl J Med. 332 (3): 133–8. doi:10.1056/NEJM199501193320301. PMID 7800004.
  6. Dodge R, Martinez FD, Cline MG, Lebowitz MD, Burrows B (1996). "Early childhood respiratory symptoms and the subsequent diagnosis of asthma". J Allergy Clin Immunol. 98 (1): 48–54. PMID 8765817.
  7. Phelan PD, Robertson CF, Olinsky A (2002). "The Melbourne Asthma Study: 1964-1999". J Allergy Clin Immunol. 109 (2): 189–94. PMID 11842286.
  8. Jones DT, Sears MR, Holdaway MD, Hewitt CJ, Flannery EM, Herbison GP; et al. (1987). "Childhood asthma in New Zealand". Br J Dis Chest. 81 (4): 332–40. PMID 3449120.
  9. 9.0 9.1 Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM; et al. (2003). "A longitudinal, population-based, cohort study of childhood asthma followed to adulthood". N Engl J Med. 349 (15): 1414–22. doi:10.1056/NEJMoa022363. PMID 14534334.
  10. Strunk RC, Weiss ST, Yates KP, Tonascia J, Zeiger RS, Szefler SJ; et al. (2006). "Mild to moderate asthma affects lung growth in children and adolescents". J Allergy Clin Immunol. 118 (5): 1040–7. doi:10.1016/j.jaci.2006.07.053. PMID 17088127.
  11. Peat JK, Woolcock AJ, Cullen K (1987). "Rate of decline of lung function in subjects with asthma". Eur J Respir Dis. 70 (3): 171–9. PMID 3569449.
  12. Kelly WJ, Hudson I, Raven J, Phelan PD, Pain MC, Olinsky A (1988). "Childhood asthma and adult lung function". Am Rev Respir Dis. 138 (1): 26–30. PMID 3059867.
  13. Ulrik CS, Lange P (1994). "Decline of lung function in adults with bronchial asthma". Am J Respir Crit Care Med. 150 (3): 629–34. PMID 8087330.
  14. Bronnimann S, Burrows B (1986). "A prospective study of the natural history of asthma. Remission and relapse rates". Chest. 90 (4): 480–4. PMID 3757559.
  15. Maddox L, Schwartz DA (2002) The pathophysiology of asthma. Annu Rev Med 53 ():477-98. DOI:10.1146/annurev.med.53.082901.103921 PMID: 11818486
  16. Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma? Thorax. 2003;58(2):163-74. PMID 12554904

Template:WH Template:WS